Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alfa (activated)
- 30 January 2007
- journal article
- case report
- Published by Wiley in Transplant Infectious Disease
- Vol. 9 (3), 233-236
- https://doi.org/10.1111/j.1399-3062.2006.00192.x
Abstract
Severe sepsis and progression to septic shock in solid organ transplant recipients is associated with a high mortality. We describe a fulminant case of septic shock in a liver transplant recipient caused by Pasteurella multocida, a gram-negative coccobacillus most commonly associated with domestic cats and dogs. P. multocida is a rare cause of bacteremia and has not been reported as a cause of septic shock following liver transplantation. In addition to standard therapy, the patient was managed with drotrecogin alpha (activated) recombinant activated protein C (APC), an evidence-based agent that has been shown to significantly improve outcome in severe sepsis in the non-transplant population. The known risk factors, clinical course, and outcomes of severe infection associated with P. multocida are also briefly reviewed. This case illustrates the need for transplant recipients and their healthcare providers to carefully consider the risk of severe infection associated with domestic animal exposure.Keywords
This publication has 19 references indexed in Scilit:
- Strategies for safe living following solid organ transplantationAmerican Journal of Transplantation, 2004
- Bacteremias in liver transplant recipients: Shift toward gram-negative bacteria as predominant pathogensLiver Transplantation, 2004
- Solid-organ transplant recipients treated with drotrecogin alfa (activated) for severe sepsisTransplantation, 2003
- Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein CBone Marrow Transplantation, 2002
- Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C PathwayScience, 2002
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Predicting bacteremia and bacteremic mortality in liver transplant recipientsLiver Transplantation, 2000
- Infection in Organ-Transplant RecipientsNew England Journal of Medicine, 1998
- Pasteurella multocida Bacteremia: Report of Thirteen Cases over Twelve Years and Review of the LiteratureScandinavian Journal of Infectious Diseases, 1987
- Pasteurella multocida InfectionsMedicine, 1984